Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Post-Election Industry Outlook: New User Fees, More Aggressive FDA

This article was originally published in The Gray Sheet

Executive Summary

With a Democrat-controlled government led by President-elect Barack Obama poised to take control, industry experts have begun speculating on the future of device regulation and reimbursement

You may also be interested in...

People In Brief

Wright Medical CEO resigns

People In Brief

Wright Medical CEO resigns

GOP Lawmakers Signal FDA Won’t Escape Congressional Crosshairs In 2009

FDA remains in the crosshairs of congressional investigators, and given that Republicans are doing some of the gunning, the agency should expect continued barrages even after the change in administrations

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts